{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:29:24Z","timestamp":1781576964767,"version":"3.54.5"},"reference-count":134,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI110769-01"],"award-info":[{"award-number":["R01AI110769-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103516"],"award-info":[{"award-number":["P20GM103516"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.01372","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T23:47:57Z","timestamp":1500508077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development"],"prefix":"10.3389","volume":"8","author":[{"given":"Wen-Yang","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-En","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Kung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01311358","article-title":"Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409)","volume":"105","author":"Aaskov","year":"1989","journal-title":"Arch. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0005179","DOI":"10.1371\/journal.pntd.0005179","article-title":"The impact of the newly licensed dengue vaccine in endemic countries","volume":"10","author":"Aguiar","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1002930","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-specific neutralization and protection by antibodies against dengue virus type 3","volume":"84","author":"Brien","year":"2010","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J. Gen. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e33451","DOI":"10.1371\/journal.pone.0033451","article-title":"A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein","volume":"7","author":"Chan","year":"2012","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4269\/ajtmh.1991.44.481","article-title":"Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever","volume":"44","author":"Churdboonchart","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","article-title":"Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody","volume":"20","author":"Cockburn","year":"","journal-title":"Structure"},{"key":"B14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/emboj.2011.439","article-title":"Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus","volume":"31","author":"Cockburn","year":"","journal-title":"EMBO J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/JVI.02273-12","article-title":"Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop","volume":"87","author":"Costin","year":"2013","journal-title":"J. Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e4991","DOI":"10.1371\/journal.pone.0004991","article-title":"Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens","volume":"4","author":"Crill","year":"2009","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fimmu.2012.00334","article-title":"Sculpting humoral immunity through dengue vaccination to enhance protective immunity","volume":"3","author":"Crill","year":"2012","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e7425","DOI":"10.1371\/journal.pone.0007425","article-title":"Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3)","volume":"4","author":"da Silva","year":"2009","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1188","DOI":"10.1371\/journal.pntd.0001188","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection","volume":"5","author":"de Alwis","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"de Alwis","year":"2014","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus","volume":"7","author":"Dowd","year":"2011","journal-title":"PLoS Pathog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.4049\/jimmunol.0903262","article-title":"Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue","volume":"184","author":"Dung","year":"2010","journal-title":"J. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/infdis\/jiq059","article-title":"Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic","volume":"203","author":"Durbin","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1004072","DOI":"10.1371\/journal.ppat.1004072","article-title":"Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement","volume":"10","author":"Edeling","year":"2014","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"Fibriansah","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1002181","DOI":"10.1371\/journal.pmed.1002181","article-title":"The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (dengvaxia): a model comparison study","volume":"13","author":"Flasche","year":"2016","journal-title":"PLoS Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0003749","DOI":"10.1371\/journal.pntd.0003749","article-title":"The complexity of a dengue vaccine: a review of the human antibody response","volume":"9","author":"Flipse","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e01461","DOI":"10.1128\/mBio.01461-15","article-title":"A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies","volume":"6","author":"Gallichotte","year":"2015","journal-title":"MBio"},{"key":"B36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","article-title":"Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus","volume":"366","author":"Gromowski","year":"2007","journal-title":"Virology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1128\/JVI.00606-08","article-title":"Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus","volume":"82","author":"Gromowski","year":"2008","journal-title":"J. Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","article-title":"Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward","volume":"33","author":"Guy","year":"2015","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.4049\/jimmunol.1500918","article-title":"Single-cell analysis of B cell\/antibody cross-reactivity using a novel multicolor fluorospot assay","volume":"195","author":"Hadjilaou","year":"2015","journal-title":"J. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/infdis\/jiw340","article-title":"Critique of World Health Organization recommendation of a dengue vaccine","volume":"214","author":"Halstead","year":"2016","journal-title":"J. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.4161\/hv.25562","article-title":"Persistence of Th1\/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore","volume":"9","author":"Harenberg","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.4049\/jimmunol.176.5.2825","article-title":"The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection","volume":"176","author":"Huang","year":"2006","journal-title":"J. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1743-422X-9-115","article-title":"Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement","volume":"9","author":"Hughes","year":"2012","journal-title":"Virol. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/vim.2007.0050","article-title":"Antibody to dengue 1 detected more than 60 years after infection","volume":"20","author":"Imrie","year":"2007","journal-title":"Viral Immunol."},{"key":"B53","first-page":"221","article-title":"Antibody responses to dengue virus infection","volume-title":"Dengue and Dengue Hemorrhagic Fever","author":"Innis","year":"1997"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.vaccine.2014.01.040","article-title":"A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available","volume":"32","author":"Ishikawa","year":"2014","journal-title":"Vaccine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"13845","DOI":"10.1128\/JVI.02086-14","article-title":"Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination","volume":"88","author":"Jarmer","year":"2014","journal-title":"J. Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J. Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrmicro1326","article-title":"Virus membrane-fusion proteins: more than one way to make a hairpin","volume":"4","author":"Kielian","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"Lai","year":"2008","journal-title":"J. Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e2451","DOI":"10.1371\/journal.pntd.0002451","article-title":"Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases","volume":"7","author":"Lai","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1447","DOI":"10.1371\/journal.pntd.0001447","article-title":"Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high-throughput assay","volume":"6","author":"Lin","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.vaccine.2015.09.101","article-title":"Preclinical and clinical development of a dengue recombinant subunit vaccine","volume":"33","author":"Manoff","year":"2015","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI118964","article-title":"Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a","volume":"98","author":"Mathew","year":"1996","journal-title":"J. Clin. Invest."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/infdis\/jir607","article-title":"B-cell responses during primary and secondary dengue virus infections in humans","volume":"204","author":"Mathew","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B67","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0042-6822(92)90450-4","article-title":"Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein","volume":"187","author":"Megret","year":"1992","journal-title":"Virology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1073\/pnas.1317350111","article-title":"Dengue virus envelope protein domain I\/II hinge determines long-lived serotype-specific dengue immunity","volume":"111","author":"Messer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"E2738","DOI":"10.1073\/pnas.1506982112","article-title":"Dengue virus envelope protein domain I\/II hinge determines long-lived serotype-specific dengue immunity","volume":"112","author":"Messer","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.4049\/jimmunol.1200227","article-title":"Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity","volume":"188","author":"Midgley","year":"2012","journal-title":"J. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e02041","DOI":"10.1128\/JVI.02041-16","article-title":"Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 infection and vaccination","volume":"91","author":"Nivarthi","year":"2017","journal-title":"J Virol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","article-title":"Reduced risk of disease during postsecondary dengue virus infections","volume":"208","author":"Olkowski","year":"2013","journal-title":"J. Infect. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.antiviral.2008.05.004","article-title":"Closing the door on flaviviruses: entry as a target for antiviral drug design","volume":"80","author":"Perera","year":"2008","journal-title":"Antiviral Res."},{"key":"B80","first-page":"747","article-title":"Flaviviruses","volume-title":"Fields Virology, 6th Edn","author":"Pierson","year":"2013"},{"key":"B81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B82","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1128\/JVI.03203-15","article-title":"B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts","volume":"90","author":"Priyamvada","year":"2016","journal-title":"J. Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1114.e10","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"11800","DOI":"10.1128\/JVI.05237-11","article-title":"A fusion-loop antibody enhances the infectious properties of immature flavivirus particles","volume":"85","author":"Rodenhuis-Zybert","year":"2011","journal-title":"J. Virol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1000718","DOI":"10.1371\/journal.ppat.1000718","article-title":"Immature dengue virus: a veiled pathogen?","volume":"6","author":"Rodenhuis-Zybert","year":"2010","journal-title":"PLoS Pathog."},{"key":"B87","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.1998.9200","article-title":"Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica","volume":"246","author":"Roehrig","year":"1998","journal-title":"Virology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1128\/JVI.78.5.2648-2652.2004","article-title":"Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein","volume":"78","author":"Roehrig","year":"2004","journal-title":"J. Virol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1016\/j.vaccine.2015.09.104","article-title":"Analysis of cell-mediated immune responses in support of dengue vaccine development efforts","volume":"33","author":"Rothman","year":"2015","journal-title":"Vaccine"},{"key":"B91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.vaccine.2015.05.010","article-title":"The dengue vaccine pipeline: Implications for the future of dengue control","volume":"33","author":"Schwartz","year":"2015","journal-title":"Vaccine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"12","author":"Screaton","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B96","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<322::AID-JMV17>3.0.CO;2-5","article-title":"Retrospective study of Western blot profiles in immune sera of natural dengue virus infections","volume":"57","author":"Se-Thoe","year":"1999","journal-title":"J. Med. Virol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J. Virol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e1000823","DOI":"10.1371\/journal.ppat.1000823","article-title":"The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1","volume":"6","author":"Shrestha","year":"2010","journal-title":"PLoS Pathog."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e00873","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"","journal-title":"MBio"},{"key":"B100","doi-asserted-by":"publisher","first-page":"12233","DOI":"10.1128\/JVI.00247-14","article-title":"Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones","volume":"88","author":"Smith","year":"2014","journal-title":"J. Virol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/infdis\/jit119","article-title":"Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics","volume":"207","author":"Smith","year":"","journal-title":"J. Infect. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/JVI.01805-15","article-title":"Dengue virus prM-specific human monoclonal antibodies with virus replication enhancing properties recognize a single immunodominant antigenic site","volume":"90","author":"Smith","year":"2015","journal-title":"J. Virol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1128\/JVI.06335-11","article-title":"Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection","volume":"86","author":"Smith","year":"2012","journal-title":"J. Virol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J. Virol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1128\/JVI.00432-07","article-title":"Type and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes","volume":"81","author":"Sukupolvi-Petty","year":"2007","journal-title":"J. Virol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J. Virol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1128\/JVI.01314-13","article-title":"Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection","volume":"87","author":"Sukupolvi-Petty","year":"2013","journal-title":"J. Virol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"139r","DOI":"10.1126\/scitranslmed.3003888","article-title":"The structural basis for serotype-specific neutralization of dengue virus by a human antibody","volume":"4","author":"Teoh","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1056\/NEJMe1413146","article-title":"Preventing dengue - is the possibility now a reality?","volume":"372","author":"Thomas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e1000453","DOI":"10.1371\/journal.ppat.1000453","article-title":"A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes","volume":"5","author":"Thompson","year":"2009","journal-title":"PLoS Pathog."},{"key":"B111","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1128\/JVI.00273-15","article-title":"Complexity of neutralization antibodies against multiple dengue viral serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies","volume":"89","author":"Tsai","year":"2015","journal-title":"J. Virol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1128\/JVI.00871-13","article-title":"High avidity and potent neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection","volume":"87","author":"Tsai","year":"2013","journal-title":"J. Virol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1128\/cdli.7.5.856-857.2000","article-title":"Human Dengue antibodies against structural and nonstructural proteins","volume":"7","author":"Valdes","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e1003761","DOI":"10.1371\/journal.ppat.1003761","article-title":"The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein","volume":"9","author":"VanBlargan","year":"2013","journal-title":"PLoS Pathog."},{"key":"B115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4269\/ajtmh.1999.60.693","article-title":"Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections","volume":"60","author":"Vaughn","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B116","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e1003458","DOI":"10.1371\/journal.ppat.1003458","article-title":"Dissection of antibody specificities induced by yellow fever vaccination","volume":"9","author":"Vratskikh","year":"2013","journal-title":"PLoS Pathog."},{"key":"B118","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody","volume":"392","author":"Wahala","year":"2009","journal-title":"Virology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fimmu.2014.00093","article-title":"T-cell immunity to infection with dengue virus in humans","volume":"5","author":"Weiskopf","year":"2014","journal-title":"Front. Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/jvi.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J. Virol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B122","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","article-title":"Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD\u2122 vaccine?","volume":"15","author":"Whitehead","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/infdis\/jiw341","article-title":"Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine","volume":"214","author":"Wilder-Smith","year":"2016","journal-title":"J. Infect. Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3285","article-title":"Tools to therapeutically harness the human antibody response","volume":"12","author":"Wilson","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"B125","volume-title":"Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 3rd Edn","year":"2009"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1128\/JVI.06075-11","article-title":"Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans","volume":"86","author":"Wrammert","year":"2012","journal-title":"J. Virol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.4049\/jimmunol.1201688","article-title":"Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes","volume":"189","author":"Xu","year":"2012","journal-title":"J. Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"B129","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B130","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nsb990","article-title":"Visualization of membrane protein domains by cryo-electron microscopy of dengue virus","volume":"10","author":"Zhang","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1128\/JVI.01886-10","article-title":"Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice","volume":"85","author":"Zlatkovic","year":"2011","journal-title":"J. Virol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e1568","DOI":"10.1371\/journal.pntd.0001568","article-title":"Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans","volume":"6","author":"Zompi","year":"2012","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.01372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T21:44:02Z","timestamp":1569879842000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.01372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":134,"alternative-id":["10.3389\/fmicb.2017.01372"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.01372","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]},"article-number":"1372"}}